Three prominent Chinese executives discuss the progress of local companies in drug innovation and the evolving regulatory environment.
{iframe}https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/whats-next-for-pharma-innovation-in-china?cid=other-eml-alt-mip-mck-oth-1710&hlkid=7c63407c9d134d0889c3acf8f3b25591&hctky=3027237&hdpid=001a5388-2ecf-4f39-b534-6fdd99bc7190{/iframe}